Prisco D - Search Results

1

Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.

Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG. Falciani M, et al. Among authors: prisco d. Thromb Haemost. 1998 Mar;79(3):495-9. Thromb Haemost. 1998. PMID: 9531029

2

Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.

Rogolino A, Coccia ME, Fedi S, Gori AM, Cellai AP, Scarselli GF, Prisco D, Abbate R. Rogolino A, et al. Among authors: prisco d. Blood Coagul Fibrinolysis. 2003 Apr;14(3):277-82. doi: 10.1097/01.mbc.0000061296.28953.d0. Blood Coagul Fibrinolysis. 2003. PMID: 12695751

3

Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarction.

Prisco D, Paniccia R, Gensini GF, Coppo M, Colella A, Filippini M, Brunelli T, Abbate R, Neri Serneri GG. Prisco D, et al. Haemostasis. 1993 Nov-Dec;23(6):308-13. doi: 10.1159/000216893. Haemostasis. 1993. PMID: 8034236 Clinical Trial.

4

Fibrinogen and factor VIIag in healthy adolescents: the Floren-teen (Florence teenager) Study.

Prisco D, Fedi S, Brunelli T, Cellai AP, Hagi MI, Gianni R, Santoro E, Cappelletti C, Pepe G, Gensini GF, Abbate R. Prisco D, et al. Thromb Haemost. 1996 May;75(5):778-81. Thromb Haemost. 1996. PMID: 8725723

5

Platelet and blood clotting activation in patients with mitral valve prolapse.

Martini F, Zuppiroli A, Gori A, Chiarantini E, Fedi S, Prisco D, Cellai A, Boddi V, Abbate R, Dolara A, Gensini G. Martini F, et al. Among authors: prisco d. Thromb Res. 1996 Aug 15;83(4):299-306. doi: 10.1016/0049-3848(96)00138-7. Thromb Res. 1996. PMID: 8870174

6

Prevalence of factor V Leiden mutation in non-European populations.

Pepe G, Rickards O, Vanegas OC, Brunelli T, Gori AM, Giusti B, Attanasio M, Prisco D, Gensini GF, Abbate R. Pepe G, et al. Among authors: prisco d. Thromb Haemost. 1997 Feb;77(2):329-31. Thromb Haemost. 1997. PMID: 9157591

7

The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).

Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, Fatini C, Capanni M, Simonetti I, Gensini GF. Abbate R, et al. Among authors: prisco d. Thromb Haemost. 1998 Apr;79(4):727-30. Thromb Haemost. 1998. PMID: 9569181

8

Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin.

Attanasio M, Gori AM, Giusti B, Pepe G, Comeglio P, Brunelli T, Prisco D, Abbate R, Gensini GF, Neri Serneri GG. Attanasio M, et al. Among authors: prisco d. Thromb Haemost. 1998 May;79(5):959-62. Thromb Haemost. 1998. PMID: 9609229

9

Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease.

Prisco D, Paniccia R, Bandinelli B, Gori AM, Attanasio M, Giusti B, Comeglio M, Abbate R, Gensini GF, Serneri GG. Prisco D, et al. Int J Clin Lab Res. 1998;28(3):170-3. doi: 10.1007/s005990050038. Int J Clin Lab Res. 1998. PMID: 9801927 Clinical Trial.

10

Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.

Gori AM, Pepe G, Attanasio M, Falciani M, Abbate R, Prisco D, Fedi S, Giusti B, Brunelli T, Giusti B, Brunelli T, Comeglio P, Gensini GF, Neri Serneri GG. Gori AM, et al. Among authors: prisco d. Thromb Haemost. 1999 Apr;81(4):589-93. Thromb Haemost. 1999. PMID: 10235445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters